Medreich has six manufacturing facilities built to comply with standards stipulated by International Regulatory bodies. The facility has been validated through successful inspections by the UK MHRA, AUSTRALIA TGA, PICS, MCC SOUTH AFRICA, CANADA HEALTH resulting in cGMP compliance / certification / accreditations by these regulatory bodies. Brief description of each of the facility is as follows:

Dedicated Betalactum Facility

This facility has the capability to manufacture all oral dosage forms of capsules, tablets, and dry powder suspensions.

Having achieved technology absorption to manufacture difficult product like Co-amoxiclav and having received quality approvals, this facility offers compelling value for Medreich's customers to forge alliance.

Facility is equipped with best of the equipments to formulate, fill, and package the products in diversity of formats.

Facility has an independent Quality Control Laboratory duly equipped to perform all tests including microbiology. Facility also has an independent site Quality Assurance Team responsible for documentation compliance and final product release.